Siarez, Danilo, N/A. A.

HRN: 23-16-31  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2023
CEFTAZIDIME 1GM (VIAL)
06/21/2023
06/28/2023
IV
1 Gram
Q8
Septicemia
Waiting Final Action 
07/31/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/31/2023
07/31/2023
IV
4.5gms
LD
Sepsis
Waiting Final Action 
07/31/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
08/01/2023
08/08/2023
IV
2.25gms
Q6
Sepsis
Waiting Final Action 
10/15/2023
CEFTAZIDIME 1GM (VIAL)
10/15/2023
10/21/2023
IV
1 G
Q8
Aspiration Pneumonia
Waiting Final Action 
10/09/2023
CEFTAZIDIME 1GM (VIAL)
10/17/2023
10/24/2023
IV
2g
Q8hr
Aspiration Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: